|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52558953
???header.onlineuser??? :
859
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"_"???jsp.browse.items-by-author.description???
Showing items 71-80 of 4992 (500 Page(s) Totally)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
View [10|25|50] records per page
| 國立成功大學 |
2024-12-18 |
Planar XY magnetic glass state in the Gd2ScNbO7 pyrochlore
|
Mauws;C;Beare;J;Rutherford;M, R.;Su;Y;Sharma;S;Nugent;M;Lee;M, K.;Chang;L, J.;Dunsiger;S, R.;Gardner;J, S.;Luke;G, M.;Wiebe;C, R. |
| 國立成功大學 |
2024-12-18 |
Atomic oxygen ion retrieval from 630.0 nm airglow during geomagnetically quiet periods: a mid-latitude case study near Irkutsk
|
Duann;Y;Chang;L, C.;Chiu;Y, -c.;Salinas;C, C. C. J. H.;Dmitriev;A, V.;Ratovsky;K, G.;Medvedeva;I, V.;Vasilyev;R;Mikhalev;A, V.;Liu;J, Y.;Lin;C, H.;Fang;T, -w. |
| 國立成功大學 |
2024-12-15 |
Exploit and elucidate chaperone assisted PET hydrolase for upcycling plastics
|
Ting;Wan-Wen;Yu;Jie-Yao;Hsiang;Chuan-Chieh;Tan;Shih-;I;Chang;Chang-Chun;Huang;Hsiang-Ling;Yu;Chi-Hua;Hu;Ruei-En;Ma;Hsing-Ning;Ng;-Son, I. |
| 國立成功大學 |
2024-12-15 |
An ultrafast, stable and highly reversible nickel magnesium vanadate cathode for magnesium ion batteries
|
Thirbika;S;Kaveevivitchai;W;Prabhu;Ramesh, M. |
| 國立成功大學 |
2024-12-15 |
An ultrafast, stable and highly reversible nickel magnesium vanadate cathode for magnesium ion batteries
|
Thirbika;S;Kaveevivitchai;W;Prabhu;Ramesh, M. |
| 國立成功大學 |
2024-12-1 |
Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT as fi rst-line (1L) treatment for recurrent or metastatic nasopharyngeal cancer (NPC): 3-year follow-up from the RATIONALE-309 study
|
Fang;W, F.;Pan;J;Wang;H;Qu;S;Chen;N;Chen;X;Sun;Y;He;X;Hu;C;Lin;L;Yen;C, J.;Wu;Y;Yuan;S;Chen;C;Yang;Y;Lean;S;Zhang;L |
| 國立成功大學 |
2024-12-1 |
Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT as fi rst-line (1L) treatment for recurrent or metastatic nasopharyngeal cancer (NPC): 3-year follow-up from the RATIONALE-309 study
|
Fang;W, F.;Pan;J;Wang;H;Qu;S;Chen;N;Chen;X;Sun;Y;He;X;Hu;C;Lin;L;Yen;C, J.;Wu;Y;Yuan;S;Chen;C;Yang;Y;Lean;S;Zhang;L |
| 國立成功大學 |
2024-12-1 |
Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT as fi rst-line (1L) treatment for recurrent or metastatic nasopharyngeal cancer (NPC): 3-year follow-up from the RATIONALE-309 study
|
Fang;W, F.;Pan;J;Wang;H;Qu;S;Chen;N;Chen;X;Sun;Y;He;X;Hu;C;Lin;L;Yen;C, J.;Wu;Y;Yuan;S;Chen;C;Yang;Y;Lean;S;Zhang;L |
| 國立成功大學 |
2024-12-1 |
Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT as fi rst-line (1L) treatment for recurrent or metastatic nasopharyngeal cancer (NPC): 3-year follow-up from the RATIONALE-309 study
|
Fang;W, F.;Pan;J;Wang;H;Qu;S;Chen;N;Chen;X;Sun;Y;He;X;Hu;C;Lin;L;Yen;C, J.;Wu;Y;Yuan;S;Chen;C;Yang;Y;Lean;S;Zhang;L |
| 國立成功大學 |
2024-12-1 |
Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT as fi rst-line (1L) treatment for recurrent or metastatic nasopharyngeal cancer (NPC): 3-year follow-up from the RATIONALE-309 study
|
Fang;W, F.;Pan;J;Wang;H;Qu;S;Chen;N;Chen;X;Sun;Y;He;X;Hu;C;Lin;L;Yen;C, J.;Wu;Y;Yuan;S;Chen;C;Yang;Y;Lean;S;Zhang;L |
Showing items 71-80 of 4992 (500 Page(s) Totally)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
View [10|25|50] records per page
|
